Clinical trials
Kidney Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 5 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Pfizer | 8 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Amgen | 2 |
| Aesculap AG | 1 |
| Arcus Biosciences, Inc. | 1 |
| Association of Urologic Oncology (AUO) | 1 |
| AvenCell Europe GmbH | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 36 |
| Carcinoma, Renal Cell | 20 |
| Colorectal Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Neoplasms | 5 |
| Head and Neck Neoplasms | 4 |
| Melanoma | 4 |
| Breast Neoplasms | 3 |
| Colonic Neoplasms | 3 |
| Esophageal Neoplasms | 3 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.